NEURAXIS, INC. Investing Cash Flow
NEURAXIS, INC. (NRXS) reported Investing Cash Flow of -$6.30 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-11
- NEURAXIS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$105.86K.
- NEURAXIS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $0.00.
- NEURAXIS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-06-30 was -$7.29K.
- NEURAXIS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-03-31 was -$18.00K.
- NEURAXIS, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$131.15K.
- NEURAXIS, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$27.78K.
- NEURAXIS, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$71.78K.
- NEURAXIS, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$61.20K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$6.30K 10-Q · filed 2026-08-11 | |||
| 2025-12-31 | -$105.86K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$105.86K derived: sum of 2 quarters · filed 2026-03-19 | -$113.15K derived: sum of 3 quarters · filed 2026-03-19 | -$131.15K 10-K · filed 2026-03-19 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-10 | -$7.29K derived: sum of 2 quarters · filed 2025-11-10 | -$25.29K 10-Q · filed 2025-11-10 | -$25.29K derived: sum of 4 quarters · filed 2026-05-12 |
| 2025-06-30 | -$7.29K 10-Q · filed 2025-08-12 | -$25.29K 10-Q · filed 2026-08-11 | -$25.29K derived: sum of 3 quarters · filed 2026-05-12 | -$29.66K derived: sum of 4 quarters · filed 2026-05-12 |
| 2025-03-31 | -$18.00K 10-Q · filed 2026-05-12 | -$18.00K derived: sum of 2 quarters · filed 2026-05-12 | -$22.37K derived: sum of 3 quarters · filed 2026-05-12 | -$31.05K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$4.37K derived: sum of 2 quarters · filed 2026-03-19 | -$13.05K derived: sum of 3 quarters · filed 2026-03-19 | -$27.78K 10-K · filed 2026-03-19 |
| 2024-09-30 | -$4.37K 10-Q · filed 2025-11-10 | -$13.05K derived: sum of 2 quarters · filed 2025-11-10 | -$27.78K 10-Q · filed 2025-11-10 | -$43.82K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$8.69K 10-Q · filed 2025-08-12 | -$23.41K 10-Q · filed 2025-08-12 | -$39.45K derived: sum of 3 quarters · filed 2025-08-12 | -$82.12K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$14.72K 10-Q · filed 2025-05-12 | -$30.76K derived: sum of 2 quarters · filed 2025-05-12 | -$73.44K derived: sum of 3 quarters · filed 2025-05-12 | -$78.89K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$16.04K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$58.71K derived: sum of 2 quarters · filed 2025-03-20 | -$64.17K derived: sum of 3 quarters · filed 2025-03-20 | -$71.78K 10-K · filed 2025-03-20 |
| 2023-09-30 | -$42.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$48.13K derived: sum of 2 quarters · filed 2024-11-12 | -$55.74K 10-Q · filed 2024-11-12 | -$105.56K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$5.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$13.07K 10-Q · filed 2024-08-09 | -$62.88K derived: sum of 3 quarters · filed 2024-08-09 | -$24.46K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | -$7.61K 10-Q · filed 2024-05-20 | -$57.42K derived: sum of 2 quarters · filed 2024-05-20 | -$19.00K derived: sum of 3 quarters · filed 2024-05-20 | |
| 2022-12-31 | -$49.81K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$11.39K derived: sum of 2 quarters · filed 2024-04-16 | -$61.20K 10-K · filed 2024-04-16 | |
| 2022-09-30 | $38.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | -$11.39K 10-Q · filed 2023-11-20 | ||
| 2022-06-30 | -$49.81K 10-Q · filed 2023-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |